
Inconclusive phase II trial of oestrogen supplements for MS
A clinical trial of sex hormone estriol (oestrogen) supplementation in women with MS has not found a definitive

A clinical trial of sex hormone estriol (oestrogen) supplementation in women with MS has not found a definitive

Low levels of vitamin D, UV radiation, and sun exposure are well established risk factors for MS. However,

It is known that people develop MS due to a combination of risk genes and environmental factors. One

Last week saw the biggest event on the international MS research calendar, the 2015 European Committee for Treatment

MS results from the loss of myelin, the insulating coating of nerve fibres, in the brain and spinal

Genentech, a biotechnology company owned by Roche Pharmaceuticals, has announced promising results from a phase III clinical trial

Since 2008 people with MS have been able to make a very special gift to MS research by

During the week of 7 – 13 September, MS Research Australia, Include a Charity and 140 other charities

During September, MS Research Australia and over 140 other charities across Australia, will be working together with the